Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1.

[1]  R. Flower,et al.  Lipocortin-1: cellular mechanisms and clinical relevance. , 1994, Trends in pharmacological sciences.

[2]  M. Perretti,et al.  Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1 , 1997, British journal of pharmacology.

[3]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[4]  V. Gerke,et al.  A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. , 2000, Molecular cell.

[5]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[6]  M. Perretti,et al.  Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. , 2001, The American journal of pathology.

[7]  Philip M Murphy,et al.  Formyl-peptide receptors revisited. , 2002, Trends in immunology.

[8]  S. Lockett,et al.  Identification of Neutrophil Granule Protein Cathepsin G as a Novel Chemotactic Agonist for the G Protein-Coupled Formyl Peptide Receptor 12 , 2004, The Journal of Immunology.

[9]  W. Gong,et al.  Silencing the Formylpeptide Receptor FPR by Short-Interfering RNA , 2004, Molecular Pharmacology.

[10]  Li Mao,et al.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry , 2004, Clinical & Experimental Metastasis.

[11]  Fang Liu,et al.  Overexpression of annexin 1 in pancreatic cancer and its clinical significance. , 2004, World journal of gastroenterology.

[12]  X. Bian,et al.  Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. , 2005, Journal of the National Cancer Institute.

[13]  A. Yoshimura,et al.  Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-371 , 2005, The Journal of Immunology.

[14]  F. Boulay,et al.  Human mitochondria‐derived N‐formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes‐derived peptides preferentially activate FPR , 2005, European journal of immunology.

[15]  M. Perretti,et al.  Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors* , 2006, Journal of Biological Chemistry.

[16]  X. Bian,et al.  Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. , 2007, Cancer research.

[17]  Jian Huang,et al.  G-protein coupled chemoattractant receptors and cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[18]  X. Bian,et al.  Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G‐protein coupled formylpeptide receptor FPR , 2008, The Journal of pathology.

[19]  X. Bian,et al.  Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression. , 2008, Cancer letters.

[20]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[21]  J. Maublant,et al.  Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. , 2009, Biochimica et biophysica acta.

[22]  Marc Parmentier,et al.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family , 2009, Pharmacological Reviews.

[23]  M. Yi,et al.  Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice , 2009, Proceedings of the National Academy of Sciences.

[24]  X. Bian,et al.  Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation. , 2009, Carcinogenesis.

[25]  F. Marini,et al.  The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells , 2009, Proceedings of the National Academy of Sciences.